Latest immunotherapy news
Subset of Patients With Follicular Lymphoma Can Achieve Cure With CHOP-Based Chemoimmunotherapy
posted March 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
AAAAI: Omalizumab as Effective as Multifood Oral Immunotherapy for Individuals With Food Allergy
posted March 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
AAAAI: No Increase Seen in Asthma Exacerbations With ICI Use for Melanoma, Renal Cell Carcinoma
posted March 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Perioperative Enfortumab Vedotin + Pembrolizumab Tied to Improved Outcomes With Bladder Cancer
posted February 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Local Recurrence Rate Low After R0 Resection of Soft Tissue Sarcoma Tumors 
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Postoperative Complications Elevated for Patients With Systemic Lupus Erythematosus .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers Related Articles
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors Monthly Specialist Briefings
Stay Connected
